Speaker

Timothy Miller holds the position of David Clayson professor of neurology at the School of Medicine at Washington University in St Louis, in which he serves as the principal investigator on multiple clinical and research studies. He also directs the ALSCenter and the Miller Laboratory, also based in the School of Medicine at Washington University in St Louis. His group focuses on developing novel therapies for neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS) and tauopathies. Miller has pioneered work with antisense oligonucleotides (ASOs) and led and completed a first-in-man phase I clinical trial of ASOs in SOD1-related ALS. He received the 2018 Sheila Essey Award for ALS research and was part of the team that received the 2019 Healey Center International Prize for Innovation in ALS. Miller currently serves as the co-chair of the Northeast ALS (NEALS) consortium.

« Go Back